BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16453027)

  • 1. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.
    Blanchard C; Wang N; Stringer KF; Mishra A; Fulkerson PC; Abonia JP; Jameson SC; Kirby C; Konikoff MR; Collins MH; Cohen MB; Akers R; Hogan SP; Assa'ad AH; Putnam PE; Aronow BJ; Rothenberg ME
    J Clin Invest; 2006 Feb; 116(2):536-47. PubMed ID: 16453027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
    Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
    Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
    Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.
    Blanchard C; Mingler MK; Vicario M; Abonia JP; Wu YY; Lu TX; Collins MH; Putnam PE; Wells SI; Rothenberg ME
    J Allergy Clin Immunol; 2007 Dec; 120(6):1292-300. PubMed ID: 18073124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
    Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
    Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
    Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia.
    Mishra A; Wang M; Pemmaraju VR; Collins MH; Fulkerson PC; Abonia JP; Blanchard C; Putnam PE; Rothenberg ME
    Gastroenterology; 2008 Jan; 134(1):204-14. PubMed ID: 18166354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism.
    Mishra A; Rothenberg ME
    Gastroenterology; 2003 Nov; 125(5):1419-27. PubMed ID: 14598258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.
    Blanchard C; Stucke EM; Burwinkel K; Caldwell JM; Collins MH; Ahrens A; Buckmeier BK; Jameson SC; Greenberg A; Kaul A; Franciosi JP; Kushner JP; Martin LJ; Putnam PE; Abonia JP; Wells SI; Rothenberg ME
    J Immunol; 2010 Apr; 184(7):4033-41. PubMed ID: 20208004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway.
    Zuo L; Fulkerson PC; Finkelman FD; Mingler M; Fischetti CA; Blanchard C; Rothenberg ME
    J Immunol; 2010 Jul; 185(1):660-9. PubMed ID: 20543112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic esophagitis: pathogenesis, genetics, and therapy.
    Blanchard C; Wang N; Rothenberg ME
    J Allergy Clin Immunol; 2006 Nov; 118(5):1054-9. PubMed ID: 17088129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal remodeling in pediatric eosinophilic esophagitis.
    Aceves SS; Newbury RO; Dohil R; Bastian JF; Broide DH
    J Allergy Clin Immunol; 2007 Jan; 119(1):206-12. PubMed ID: 17208603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A striking local esophageal cytokine expression profile in eosinophilic esophagitis.
    Blanchard C; Stucke EM; Rodriguez-Jimenez B; Burwinkel K; Collins MH; Ahrens A; Alexander ES; Butz BK; Jameson SC; Kaul A; Franciosi JP; Kushner JP; Putnam PE; Abonia JP; Rothenberg ME
    J Allergy Clin Immunol; 2011 Jan; 127(1):208-17, 217.e1-7. PubMed ID: 21211656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic pathogenesis of eosinophilic esophagitis.
    Blanchard C; Rothenberg ME
    Gastrointest Endosc Clin N Am; 2008 Jan; 18(1):133-43; x. PubMed ID: 18061107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
    Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis.
    Sherrill JD; Gao PS; Stucke EM; Blanchard C; Collins MH; Putnam PE; Franciosi JP; Kushner JP; Abonia JP; Assa'ad AH; Kovacic MB; Biagini Myers JM; Bochner BS; He H; Hershey GK; Martin LJ; Rothenberg ME
    J Allergy Clin Immunol; 2010 Jul; 126(1):160-5.e3. PubMed ID: 20620568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation.
    Fulkerson PC; Fischetti CA; McBride ML; Hassman LM; Hogan SP; Rothenberg ME
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16418-23. PubMed ID: 17060636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
    Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
    J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
    Mould AW; Matthaei KI; Young IG; Foster PS
    J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.